{
  "docId": "019de076-9b15-737c-b05c-8347f7a98ad7",
  "docSlug": "10fcfebbf5ba7c34c2d4aec7e3b05ed6",
  "documentTitle": "Enochian Biosciences | Investor Presentation Deck | 28 slides",
  "authorId": "enochian-biosciences",
  "authorName": "Renovaro Biosciences",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 28,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "solution",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-9b15-737c-b05c-8347f7a98ad7/5",
  "deckHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7",
  "deckJsonHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7.json",
  "deckAnchorHref": "/decks/019de076-9b15-737c-b05c-8347f7a98ad7#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.86,
        "x": 0.07,
        "y": 0.225
      },
      "kind": "callout",
      "text": "The basis for immune modulation at Renovaro is to retrain the immune system to better recognize and destroy diseased cells\n• Cancer: neo-antigens, Tumor Associated Antigens (TAA)\n• Infectious Disease: Pathogen-specific antigens",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4a92faa9-33f1-41e4-8449-f089c134c888",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.82,
        "x": 0.09,
        "y": 0.55
      },
      "kind": "list",
      "text": "RENB-DC11\n• Engineered Dendritic cell therapeutic vaccine (Solid tumors)\nRENB-HV12\n• Engineered T-Cell therapeutic vaccine (HIV)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ae7e147c-7098-466a-b27b-1494a3f66456",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.86,
        "x": 0.07,
        "y": 0.11
      },
      "kind": "title",
      "text": "CELL- AND GENE IMMUNOTHERAPY PLATFORMS",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3ebd515b-0f57-404f-887c-d91d1ffa7a40",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "176d96ee-3a31-49dd-b77a-f504c12dbcde",
      "evidence": "list/bullet: RENB-DC11 • Engineered Dendritic cell therapeutic vaccine (Solid tumors) RENB-HV12 • Engineered T-Cell therapeutic vaccine (HIV)",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 4,
      "beatId": "97f93e02-4861-4e2d-a328-40b8053f0e8c",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem (Identify pain)",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "The presentation identifies the problem of solid tumors and the need for effective treatment.",
      "position": 0,
      "confidence": 0.9,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    },
    {
      "to": 28,
      "from": 5,
      "beatId": "aa98e201-f5e8-4447-bd2f-449a0dcae7fe",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The presentation presents RENB-DC11 as a solution, highlighting its efficacy, manufacturing process, and potential for personalized, precision medicine.",
      "position": 2,
      "confidence": 0.9,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 6,
      "from": 4,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "1a0c31bd-83b1-44a2-a585-7a9095367a87",
      "evidence": "The presentation logically connects the market opportunity to RENB-DC11's potential.",
      "position": 0,
      "objective": "What is the market opportunity for RENB-DC11?",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.8,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}